Literature DB >> 12721819

Procalcitonin as a marker of acute pyelonephritis.

H A Repetto, P A Alarcón, M Pellegrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12721819     DOI： 10.1007/s00467-003-1101-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection.

Authors:  A Gervaix; A Galetto-Lacour; T Gueron; L Vadas; S Zamora; S Suter; E Girardin
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

2.  Procalcitonin as a marker of acute pyelonephritis in infants and children.

Authors:  Vladislav Smolkin; Ariel Koren; Raul Raz; Raul Colodner; Waheeb Sakran; Raphael Halevy
Journal:  Pediatr Nephrol       Date:  2002-06       Impact factor: 3.714

3.  Procalcitonin is a marker of severity of renal lesions in pyelonephritis.

Authors:  N Benador; C A Siegrist; D Gendrel; C Greder; D Benador; M Assicot; C Bohuon; E Girardin
Journal:  Pediatrics       Date:  1998-12       Impact factor: 7.124
  3 in total
  3 in total

Review 1.  Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.

Authors:  Nader Shaikh; Jessica L Borrell; Josh Evron; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

2.  Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.

Authors:  Kai J Shaikh; Victor A Osio; Mariska Mg Leeflang; Nader Shaikh
Journal:  Cochrane Database Syst Rev       Date:  2020-09-10

3.  Procalcitonin for the early prediction of renal parenchymal involvement in children with UTI: preliminary results.

Authors:  Aggeliki Kotoula; Stefanos Gardikis; Aggelos Tsalkidis; Elpis Mantadakis; Athanassios Zissimopoulos; Katerina Kambouri; Savvas Deftereos; Gregorios Tripsianis; Konstantinos Manolas; Athanassios Chatzimichael; George Vaos
Journal:  Int Urol Nephrol       Date:  2008-10-03       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.